Axiom University
Fusion eClinical Suite – Training Material
Fusion eClinical Suite
Data Driven Studies: Fusion is Axiom’s proprietary, easy-to-use and cost-effective eClinical solution that is focused on small to medium sized device, pharma, and biotech companies.
Over 15 fully integrated modules that connect seamlessly in one unified platform – accessible with a single sign-on.
Training Material
Axiom offers the following training material(s) available for the BAVARIAN NORDIC – CV-317-004 / CV-317-005 study:
A pioneering force in vaccines, expanding our reach and impact through life-changing solutions
A leading global provider of travel vaccines for improving public preparedness, such as mpox and smallpox vaccines.
CV-317 Study
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents.
The chikungunya virus (CHIKV) virus-like particle (VLP) vaccine is a single-dose, pre-filled syringe for intramuscular injection.